Market News

NASDAQ:MYGN News

7 stories
tradingview

Myriad Genetics, Inc. Stock 12‑Month Price Target Cut to $5.75, Implies 7% Upside

Explore more price target data and ratings for Myriad Genetics, Inc. on the Forecasts tab, and track all previous and future analyst recommendations for Myriad Genetics, Inc. in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This in…

TradingView en_IN
StocksUS
tradingview

MYRIAD GENETICS INC 2026: Revenue $190.7M, EPS ($0.46) — 10-Q Summary

Myriad Genetics Inc reported results for the 2026 quarter with revenue of $190.7M, a net loss of ($43.2M) and diluted loss per share of ($0.46), reflecting lower revenue and improved loss versus the prior-year quarter.Financial Highlights¹ Reported as “Revenue”. ² Reported as “Net loss”. ³ Reported…

TradingView en_IN
StocksUS
tradingview

Myriad Genetics, Inc. Stock 12‑Month Price Target Cut to $6.14, Implies 8% Upside

Explore more price target data and ratings for Myriad Genetics, Inc. on the Forecasts tab, and track all previous and future analyst recommendations for Myriad Genetics, Inc. in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This in…

TradingView en_IN
StocksUS